Aerin Medical announces results of randomized controlled trial supporting VivAer® for treatment of nasal airway obstruction with nasal valve collapse

(Merryman Communications) Aerin Medical Inc. today announced that the International Forum of Allergy and Rhinology has published three-month results online from the VATRAC trial, confirming the safety and efficacy of VivAer® for the treatment of nasal airway obstruction (NAO) caused by nasal valve collapse (NVC). In the study, those treated with VivAer showed significant improvement in nasal obstruction symptoms compared to the control group.